Informativa su Privacy e Cookies
Questo sito utilizza cookie tecnici funzionali, cookie analitici di terze parti anonimizzati, e cookie di terze parti che potrebbero profilare: accedendo a qualunque elemento/area del sito al di fuori di questo banner, acconsenti a ricevere i cookie secondo le tue Preferenze. Puoi liberamente consentire, negare o impostare le tue preferenze sull\'utilizzo dei Cookies tramite i link di seguito. Se vuoi saperne di più puoi consultare la pagina Informazioni su Privacy e Cookies. Ti ricordo che i Cookies saranno registrati sul tuo browser solo a seguito del tuo consenso e secondo la modalità tecniche consentite dai produttori software, puoi liberamente cancellare i Cookies in qualsiasi momento tramite l\'apposita funzione del tuo browser.  Se non consenti l\'utilizzo di alcuni Cookies si potrebbero verificare malfunzionamenti delle pagine web oppure alcuni contenuti potrebbero non funzionare. [user_consent_state] [cookie_audit columns=\"cookie,description\" heading=\"The below list details the cookies used in our website.\"]
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

No cookies to display.

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

No cookies to display.

[Articles] Rates of infection with other pathogens after a positive COVID-19 test versus a negative test in US veterans (November, 2021, to December, 2023): a retrospective cohort study

Di |2025-04-02T00:30:01+02:00Aprile 2nd, 2025|Categorie: Coronavirus Lancet|

Our results suggest that a positive test for COVID-19 (vs a negative test) was associated with increased rates of diagnosis of various infections in the 12 months following an acute SARS-CoV-2 infection. The putative long-term effects of COVID-19 on th...

[Corrections] Correction to Lancet Infection 2025; published online March 24. https://doi.org/10.1016/S1473-3099(25)00181-1

Di |2025-04-01T00:30:02+02:00Aprile 1st, 2025|Categorie: Coronavirus Lancet|

Rehman U, Liu J, Oakley R, et al. Rapidly rising rates of oropharyngeal cancer and economic burden in the UK. Lancet Infect Dis 2025; published online March 24. https://doi.org/10.1016/S1473-3099(25)00181-1—In this Correspondence, the spelling of autho...

[Articles] The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial

Di |2025-03-26T00:30:06+01:00Marzo 26th, 2025|Categorie: Coronavirus Lancet|

Vaccinating women with Tdap-IPV in pregnancy was safe and well tolerated in a sub-Saharan African setting and boosted the quantity and quality of pertussis-specific antibodies in infants in early life. Although Tdap-IPV was associated with relative blu...

[Articles] Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension

Di |2025-03-25T00:30:06+01:00Marzo 25th, 2025|Categorie: Coronavirus Lancet|

Doxy-PEP was effective in reducing bacterial STIs in this population of men who have sex with men and transgender women, including during an open-label extension when doxy-PEP efficacy was known. Doxy-PEP was well tolerated, highly acceptable, and with...

[Personal View] Tuberculosis preventive therapy: scientific and ethical considerations for trials of ultra-short regimens

Di |2025-03-22T00:30:02+01:00Marzo 22nd, 2025|Categorie: Coronavirus Lancet|

Preventive therapy remains key to the elimination of tuberculosis and is typically offered to people with presumptive Mycobacterium tuberculosis infection to prevent active disease. Although the duration of tuberculosis preventive therapy has been redu...

[Articles] Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial

Di |2025-03-20T00:30:02+01:00Marzo 20th, 2025|Categorie: Coronavirus Lancet|

Non-inferior immune responses for extended two-dose regimens of 2vHPV support dosing flexibility. For up to 24 months, one dose of 2vHPV elicited immunogenicity that was similar to one dose of 4vHPV, for which single-dose efficacy has been shown, suppo...

Torna in cima